Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
CO

COLL

Market Closed

Collegium Pharmaceutical, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & Generic
US
423 employees
CEO: Vikram Karnani
Founded: 2015
$23.36
+$0.00(+NaN%)
Market Cap
757.65M
Beta
0.72
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Based on PERT weighted analysis (confidence: high), the fair value is $320.96, implying 1264.0% upside from current levels. The stock appears significantly undervalued. Financial health scores indicate moderate fundamentals (2.6/5). Monte Carlo analysis shows low downside risk (0% of scenarios below current price). Overall, this suggests a compelling buying opportunity at current prices.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore COLL

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

COLL in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →